DK0655458T3 - Ny fremgangsmåde til fremstilling af finasterid - Google Patents

Ny fremgangsmåde til fremstilling af finasterid

Info

Publication number
DK0655458T3
DK0655458T3 DK95200270T DK95200270T DK0655458T3 DK 0655458 T3 DK0655458 T3 DK 0655458T3 DK 95200270 T DK95200270 T DK 95200270T DK 95200270 T DK95200270 T DK 95200270T DK 0655458 T3 DK0655458 T3 DK 0655458T3
Authority
DK
Denmark
Prior art keywords
finasteride
magnesium halide
new process
disclosed
preparation
Prior art date
Application number
DK95200270T
Other languages
Danish (da)
English (en)
Inventor
Ulf H Dolling
James A Mccauley
Richard J Varsolona
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26681536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0655458(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0655458T3 publication Critical patent/DK0655458T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04NPICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N5/00Details of television systems
    • H04N5/74Projection arrangements for image reproduction, e.g. using eidophor
    • H04N5/7416Projection arrangements for image reproduction, e.g. using eidophor involving the use of a spatial light modulator, e.g. a light valve, controlled by a video signal
    • H04N5/7458Projection arrangements for image reproduction, e.g. using eidophor involving the use of a spatial light modulator, e.g. a light valve, controlled by a video signal the modulator being an array of deformable mirrors, e.g. digital micromirror device [DMD]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Multimedia (AREA)
  • Signal Processing (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Seasonings (AREA)
  • Confectionery (AREA)
DK95200270T 1992-11-19 1993-11-12 Ny fremgangsmåde til fremstilling af finasterid DK0655458T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97853592A 1992-11-19 1992-11-19
US08/010,734 US5468860A (en) 1992-11-19 1993-01-29 New finasteride processes

Publications (1)

Publication Number Publication Date
DK0655458T3 true DK0655458T3 (da) 1999-09-27

Family

ID=26681536

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93203163T DK0599376T4 (da) 1992-11-19 1993-11-12 Fremgangsmåde til fremstilling af finasterid
DK95200270T DK0655458T3 (da) 1992-11-19 1993-11-12 Ny fremgangsmåde til fremstilling af finasterid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK93203163T DK0599376T4 (da) 1992-11-19 1993-11-12 Fremgangsmåde til fremstilling af finasterid

Country Status (32)

Country Link
US (3) US5468860A (fr)
EP (3) EP0823436A3 (fr)
JP (2) JPH07110875B2 (fr)
CN (1) CN1058018C (fr)
AT (2) ATE164850T1 (fr)
AU (1) AU658774B2 (fr)
BG (2) BG62362B1 (fr)
CA (1) CA2103107C (fr)
CY (1) CY2135B1 (fr)
CZ (3) CZ301160B6 (fr)
DE (4) DE599376T1 (fr)
DK (2) DK0599376T4 (fr)
DZ (1) DZ1733A1 (fr)
ES (2) ES2052476T5 (fr)
FI (4) FI107450B (fr)
GR (4) GR940300045T1 (fr)
HR (2) HRP931410B1 (fr)
HU (2) HU216195B (fr)
IL (1) IL107574A (fr)
IS (2) IS1692B (fr)
LV (2) LV12212B (fr)
MX (1) MX9307222A (fr)
MY (2) MY110410A (fr)
NO (3) NO305912B1 (fr)
PH (1) PH31120A (fr)
RO (2) RO115165B1 (fr)
RU (1) RU2120445C1 (fr)
SI (1) SI9300603B (fr)
SK (2) SK286488B6 (fr)
TW (1) TW257766B (fr)
UA (1) UA41341C2 (fr)
WO (1) WO1994011387A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
IT1270660B (it) * 1994-10-13 1997-05-07 Poli Ind Chimica Spa Procedimento microbiologico per la preparazione di 3-oxo-4-azasteroidi-17beta-carbossi sostituiti e uso dei prodotti come inibitori dell'enzima 5alfa-riduttasi
US5670643A (en) * 1995-03-16 1997-09-23 Glaxo Wellcome Inc. Method for preparing finasteride
US5585383A (en) * 1995-05-03 1996-12-17 Merck & Co., Inc. Process for crystallizing a 4-azasteroid 5alpha-reductase inhibitor
EP0859761A4 (fr) * 1995-09-15 2000-01-26 Merck & Co Inc 4-azasteroides utilises pour le traitement d'etats hyperandrogeniques
GB2338234B (en) * 1998-06-10 2000-05-03 Torcan Chemical Ltd Preparation of finasteride
ES2153789B1 (es) * 1999-07-05 2001-10-16 Raga Consultores S L Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
EP1228084A1 (fr) * 1999-11-01 2002-08-07 TORCAN CHEMICAL Ltd Production de formes polymorphes i et ii de finasteride par complexation avec des sels de metaux de groupe i ou ii
KR20030029947A (ko) * 2000-09-07 2003-04-16 닥터 레디스 레보러터리즈 리미티드 17-β-(엔-티-부틸카르바모일)-4-아자-5-α-안드로스트-1-엔-3-온의 신규의다형태 및 그 제조방법
JP2004508380A (ja) * 2000-09-07 2004-03-18 ドクター・レディーズ・ラボラトリーズ・リミテッド 17−β−(N−ter−ブチルカルバモイル)−4−アザ−5−α−アンドロスト−1−エン−3−オンの新規の多形体及びその調製方法
SK2732003A3 (en) * 2000-09-07 2004-01-08 Reddys Lab Ltd Dr Novel polymorphic form of 17-beta-(N-ter.butyl carbamoyl)-4-aza- 5-alpha-androst-1-en-3-one and a process for preparing it
KR100415858B1 (ko) * 2001-09-22 2004-01-24 한미약품 주식회사 17베타-(엔-3차-부틸카바모일)-3-온 스테로이드 화합물의제조방법
CN100428897C (zh) * 2002-08-16 2008-10-29 浙江寿峰堂生物工程有限公司 抗疲劳改善亚健康的保健食品及其制备方法
ES2206065B1 (es) * 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.
WO2004083230A1 (fr) * 2003-03-19 2004-09-30 Hetero Drugs Limited Nouvelles formes cristallines de finasteride
US7550593B2 (en) * 2003-07-03 2009-06-23 Cipla Limited Process for the preparation of finasteride Form I
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
US20070167477A1 (en) * 2006-01-13 2007-07-19 Mandava Venkata Naga Brahmeswa Processes to prepare finasteride polymorphs
US7531658B2 (en) * 2006-01-20 2009-05-12 Apotex Pharmachem Inc. Process for the preparation of 17-N-substituted-carbamoyl-4-aza-androst-1-en-3-ones
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
WO2007089267A1 (fr) 2006-02-03 2007-08-09 Jr Chem, Llc Traitement anti-vieillissement utilisant des préparations de cuivre et de zinc
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US20090076058A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched finasteride
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US9004752B2 (en) * 2008-05-05 2015-04-14 Abbvie, Inc. Method for evaluating the solubility of a crystalline substance in a polymer
CA2750636C (fr) 2009-01-23 2017-07-25 Jr Chem, Llc Traitements pour l'acne rosacee et trousses medicales pour les mettre en pratique
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74365A (en) * 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
NZ225100A (en) 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5084574A (en) * 1988-04-18 1992-01-28 Merck & Co., Inc. Dehydrogenation process
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
DE69112917T2 (de) * 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
EP0462662A3 (en) * 1990-06-20 1992-08-19 Merck & Co. Inc. 17beta-n-monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5alpha-androst-1-en-3-ones and androstan-3-ones
US5091534A (en) 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
US5120847A (en) 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
US5061801A (en) * 1990-09-24 1991-10-29 Merck & Co., Inc. Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones
CA2050824A1 (fr) * 1990-09-24 1992-03-25 John M. Williams Methode de preparation de 3-oxo-4-azaandrost-1-en-17.beta.-ones
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
FI114215B (fi) 2004-09-15
HRP20000295B1 (en) 2002-08-31
HRP931410A2 (en) 1996-06-30
ES2052476T3 (es) 1998-06-16
NO951986D0 (no) 1995-05-19
DE69317856T2 (de) 1998-11-05
BG64464B1 (bg) 2005-03-31
HU210535A9 (en) 1995-04-28
EP0599376A3 (en) 1994-09-28
JP2742409B2 (ja) 1998-04-22
RO115165B1 (ro) 1999-11-30
EP0655458B1 (fr) 1999-03-03
CN1090583A (zh) 1994-08-10
FI20040559A7 (fi) 2004-04-21
IS1671B (is) 1997-12-19
CZ301160B6 (cs) 2009-11-18
FI20010289L (fi) 2001-02-15
IS4094A (is) 1994-05-20
MY110411A (en) 1998-05-30
ES2052476T1 (es) 1994-07-16
BG99637A (bg) 1996-04-30
HRP20000295A2 (en) 2000-08-31
HRP931410B1 (en) 2000-06-30
DE599376T1 (de) 1994-12-08
ES2072848T1 (es) 1995-08-01
JPH09235294A (ja) 1997-09-09
UA41341C2 (uk) 2001-09-17
CA2103107A1 (fr) 1994-05-20
DE69323754T2 (de) 1999-10-07
US5468860A (en) 1995-11-21
SI9300603B (sl) 2004-06-30
EP0655458A3 (fr) 1996-07-10
HUT66973A (en) 1995-01-30
DE655458T1 (de) 1995-11-30
SK286488B6 (sk) 2008-11-06
LV12212A (lv) 1999-01-20
US5652365A (en) 1997-07-29
DE69323754D1 (de) 1999-04-08
DE69317856D1 (de) 1998-05-14
HK1008338A1 (en) 1999-05-07
NO305912B1 (no) 1999-08-16
CZ301191B6 (cs) 2009-12-02
MX9307222A (es) 1994-07-29
NO307888B1 (no) 2000-06-13
FI952422L (fi) 1995-05-18
PH31120A (en) 1998-02-23
BG103170A (en) 1999-09-30
RU95112521A (ru) 1997-02-10
ES2072848T3 (es) 1999-05-01
FI107450B (fi) 2001-08-15
WO1994011387A2 (fr) 1994-05-26
LV12212B (en) 1999-03-20
MY110410A (en) 1998-05-30
CZ287842B6 (en) 2001-02-14
CN1058018C (zh) 2000-11-01
AU5078793A (en) 1994-06-16
EP0655458A2 (fr) 1995-05-31
NO992580L (no) 1995-05-19
LV12460A (lv) 2000-04-20
NO990468D0 (no) 1999-02-01
HU9303275D0 (en) 1994-03-28
EP0823436A3 (fr) 1998-11-25
GR3029554T3 (en) 1999-06-30
JPH06199889A (ja) 1994-07-19
AU658774B2 (en) 1995-04-27
CA2103107C (fr) 2010-09-28
WO1994011387A3 (fr) 1994-09-29
GR940300045T1 (en) 1994-07-29
IS1692B (is) 1998-04-20
FI20010290L (fi) 2001-02-15
EP0599376B2 (fr) 2008-04-16
FI114800B (fi) 2004-12-31
FI116941B (fi) 2006-04-13
EP0823436A2 (fr) 1998-02-11
SK65995A3 (en) 1995-10-11
BG62362B1 (bg) 1999-09-30
NO307888B3 (no) 2000-06-13
ES2052476T5 (es) 2008-11-01
IL107574A0 (en) 1994-02-27
IL107574A (en) 2000-07-16
EP0599376A2 (fr) 1994-06-01
JPH07110875B2 (ja) 1995-11-29
EP0599376B1 (fr) 1998-04-08
SI9300603A (en) 1994-06-30
TW257766B (fr) 1995-09-21
IS4286A (is) 1994-05-20
RO115164B1 (ro) 1999-11-30
CZ126895A3 (en) 1995-12-13
RU2120445C1 (ru) 1998-10-20
NO307609B1 (no) 2000-05-02
FI952422A0 (fi) 1995-05-18
US5886184A (en) 1999-03-23
SK281765B6 (sk) 2001-07-10
LV12460B (en) 2000-09-20
GR3026577T3 (en) 1998-07-31
HU216195B (hu) 1999-05-28
DK0599376T4 (da) 2008-07-28
ATE164850T1 (de) 1998-04-15
ATE177112T1 (de) 1999-03-15
NO992580D0 (no) 1999-05-28
NO951986L (no) 1995-05-19
GR950300043T1 (en) 1995-07-31
DZ1733A1 (fr) 2002-02-17
NO990468L (no) 1995-05-19
CY2135B1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
DK0655458T3 (da) Ny fremgangsmåde til fremstilling af finasterid
RU95103420A (ru) Способ получения безводной фосфористой кислоты
JPS55104906A (en) Production of carbonyl selenide